4.6 Article

Evolution of neurologic symptoms in non-hospitalized COVID-19 long haulers

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

Post-acute COVID-19 syndrome in patients after 12 months from COVID-19 infection in Korea

Yoonjung Kim et al.

Summary: As the COVID-19 pandemic continues, understanding its long-term impacts is becoming more important. This study conducted two surveys on recovered patients to evaluate the long-term course of symptoms and quality of life. The results showed that COVID-19-related persistent symptoms improved over time, but neurological symptoms can last longer. Age, sex, and disease severity were identified as risk factors for persistent neuropsychiatric symptoms.

BMC INFECTIOUS DISEASES (2022)

Article Otorhinolaryngology

Olfactory Dysfunction in COVID-19 Patients: Prevalence and Prognosis for Recovering Sense of Smell

Luca D'Ascanio et al.

Summary: This study found that olfactory dysfunction is more common in COVID-19 patients compared to healthy controls, with outpatients paradoxically reporting loss of smell more commonly than inpatients. Most patients with olfactory dysfunction recovered within 30 days, indicating a favorable prognosis.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2021)

Article Immunology

Long COVID in the Faroe Islands: A Longitudinal Study Among Nonhospitalized Patients

Maria Skaalum Petersen et al.

Summary: The study showed that over half of COVID-19 patients still had at least one symptom persisting after an average of 125 days post-symptom onset, with fatigue, loss of smell and taste, and arthralgias being the most prevalent persistent symptoms. At the last follow-up, 46.9% of patients were asymptomatic compared to only 4.4% during the acute phase. Continued monitoring for long COVID is necessary.

CLINICAL INFECTIOUS DISEASES (2021)

Article Medicine, General & Internal

Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies

Melanie Dani et al.

Summary: The COVID-19 pandemic has caused unprecedented morbidity, mortality, and disruption, with a new syndrome known as 'long COVID' emerging among survivors. This syndrome, characterized by debilitating symptoms like breathlessness and palpitations, may be related to autonomic nervous system disruption post-infection. Physicians should recognize and support individuals with 'long COVID' symptoms, with a focus on managing the underlying impaired autonomic physiology.

CLINICAL MEDICINE (2021)

Article Otorhinolaryngology

Quantitative evaluation and progress of olfactory dysfunction in COVID-19

Burak Numan Ugurlu et al.

Summary: This study aimed to quantitatively analyze olfactory dysfunction in COVID-19 patients using the BSIT test, revealing a high rate of moderate-mild symptoms with a high level of recovery in the 3-month follow-up. The finding that olfactory dysfunction was the first symptom in 40% of patients suggests the importance of inquiring about olfactory functions for early disease diagnosis.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2021)

News Item Multidisciplinary Sciences

HOW VACCINATION AFFECTS THE RISK OF LONG COVID

Heidi Ledford

Summary: Coronavirus vaccines help reduce the risk of developing COVID-19, but studies differ on their protective effect against long COVID.

NATURE (2021)

Article Biochemistry & Molecular Biology

Attributes and predictors of long COVID

Carole H. Sudre et al.

Summary: Reports on long-lasting COVID-19 symptoms, known as 'long COVID', are increasing. Analysis of data from over 4,000 COVID-19 cases revealed that long COVID is more common in older individuals, those with higher body mass index, and females. Experiencing more than five symptoms in the first week of illness was associated with long COVID. A simple model showed promise in distinguishing between short and long COVID cases early in the disease.

NATURE MEDICINE (2021)

Review Chemistry, Multidisciplinary

COVID-19 Antibody Tests and Their Limitations

Guoqiang Liu et al.

Summary: COVID-19 pandemic is a global health crisis with over 2 million deaths, where the main diagnostic methods are nucleic acid PCR tests, viral antigen tests, and human antibody tests. The limitations of antibody tests include inaccuracies due to various factors such as testing windows, individual variances, and fluctuation in antibody levels.

ACS SENSORS (2021)

Article Clinical Neurology

Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables

K. W. Miskowiak et al.

Summary: This study investigated the frequency, pattern, and severity of cognitive impairments in patients 3-4 months after COVID-19 hospital discharge, finding that a majority of patients had clinically significant cognitive impairment. These impairments were associated with subjective cognitive complaints, lower quality of life, and illness variables. Further research is needed to understand the associations between cognitive sequelae of COVID-19 and lung affection, cerebral oxygen delivery, and targeted treatments for persistent cognitive impairments.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2021)

Letter Medicine, General & Internal

Assessment of Cognitive Function in Patients After COVID-19 Infection

Jacqueline H. Becker et al.

Summary: This study aims to examine rates of cognitive impairment among COVID-19 survivors and investigate the association between care setting and cognitive impairment rates.

JAMA NETWORK OPEN (2021)

Article Clinical Neurology

Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 long haulers

Edith L. Graham et al.

Summary: This study investigated the neurologic manifestations in non-hospitalized Covid-19 long haulers, revealing prominent symptoms such as brain fog and fatigue which negatively affect their cognition and quality of life.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)

Article Multidisciplinary Sciences

Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT

Melanie L. Bell et al.

Summary: Clinical presentation, outcomes, and duration of COVID-19 vary greatly among individuals. Most PASC research has focused on hospitalized patients. A population-based study in Arizona found that 68.7% of non-hospitalized individuals experienced PASC symptoms 30 days post-infection, with fatigue, shortness-of-breath, brain fog, and stress/anxiety being the most common symptoms.

PLOS ONE (2021)

Article Multidisciplinary Sciences

Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients

Sofie Bliddal et al.

Summary: Among non-hospitalized PCR-confirmed COVID-19 patients, one third were asymptomatic, while one third of symptomatic participants reported persistent symptoms. Risk factors for persistent symptoms included female sex and BMI.

SCIENTIFIC REPORTS (2021)

Article Multidisciplinary Sciences

Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study

Arne Soraas et al.

Summary: The study investigated the health status of 8786 non-hospitalized COVID-19 patients and found that 36% of positive patients rated their health somewhat or much worse than one year ago, compared to only 18% of negative patients. Symptoms such as sore throat and cough were more frequently reported in the control group.

PLOS ONE (2021)

Article Medicine, General & Internal

Characterizing long COVID in an international cohort: 7 months of symptoms and their impact

Hannah E. Davis et al.

Summary: Patients with Long COVID report prolonged, multisystem involvement and significant disability. By seven months, many patients have not yet recovered (mainly from systemic and neurological/cognitive symptoms), have not returned to previous levels of work, and continue to experience significant symptom burden.

ECLINICALMEDICINE (2021)

Article Health Care Sciences & Services

Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study

Max Augustin et al.

Summary: The study observed long-term symptoms in non-hospitalised patients post SARS-CoV-2 infection for four and seven months, identifying persistent symptoms such as shortness of breath, anosmia, ageusia, and fatigue, summarised as post-COVID syndrome (PCS).

LANCET REGIONAL HEALTH-EUROPE (2021)

Article Health Care Sciences & Services

Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adults

Helen Ward et al.

Summary: The study in England examined changes in antibody positivity at the population level following the first wave of the COVID-19 epidemic. Results showed a decline in overall antibody prevalence over time, with differences in decline among different age groups and individuals with different COVID-19 history. The findings highlight the need for widespread vaccination to confer immunity and control the epidemic.

LANCET REGIONAL HEALTH-EUROPE (2021)

Article Immunology

Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients

Frauke Muecksch et al.

Summary: Understanding the longitudinal trajectory of SARS-CoV-2 antibodies is crucial for diagnosis and immunity prediction. Different serological assays have varying suitability for surveillance and prediction of neutralization potency, with S-based assays better predicting neutralization levels over time.

JOURNAL OF INFECTIOUS DISEASES (2021)

Article Biochemistry & Molecular Biology

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

Quan-Xin Long et al.

NATURE MEDICINE (2020)

Letter Medicine, General & Internal

Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19

F. Javier Ibarrondo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Medicine, General & Internal

Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis

Mayara Lisboa Bastos et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Editorial Material Medicine, General & Internal

Management of post-acute covid-19 in primary care

Trisha Greenhalgh et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Article Medicine, Research & Experimental

Kinetics of viral load and antibody response in relation to COVID-19 severity

Yanqun Wang et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Medicine, Research & Experimental

Does COVID-19 cause permanent damage to olfactory and gustatory function?

Gamba Paolo

MEDICAL HYPOTHESES (2020)

Letter Medicine, General & Internal

From doctors as patients: a manifesto for tackling persisting symptoms of covid-19

Nisreen A. Alwan et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Article Medicine, General & Internal

Persistence of Anti-SARS-CoV-2 Antibodies in Non-Hospitalized COVID-19 Convalescent Health Care Workers

Margherita Bruni et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Article Health Care Sciences & Services

Persistent symptoms after Covid-19: qualitative study of 114 long Covid patients and draft quality principles for services

Emma Ladds et al.

BMC HEALTH SERVICES RESEARCH (2020)

Article Medicine, General & Internal

Facing up to long COVID

The Lancet

LANCET (2020)

Review Multidisciplinary Sciences

False-negative results of initial RT-PCR assays for COVID-19: A systematic review

Ingrid Arevalo-Rodriguez et al.

PLOS ONE (2020)

Article Oncology

Self-reported cognitive concerns and abilities: two sides of one coin?

Jin-Shei Lai et al.

PSYCHO-ONCOLOGY (2014)